pralnacasan has been researched along with entacapone in 1 studies
| Studies (pralnacasan) | Trials (pralnacasan) | Recent Studies (post-2010) (pralnacasan) | Studies (entacapone) | Trials (entacapone) | Recent Studies (post-2010) (entacapone) |
|---|---|---|---|---|---|
| 19 | 0 | 7 | 503 | 112 | 173 |
| Protein | Taxonomy | pralnacasan (IC50) | entacapone (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 6.8 | |
| Catechol O-methyltransferase | Homo sapiens (human) | 0.223 | |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | 1.275 | |
| Adenosine receptor A2a | Homo sapiens (human) | 2.32 | |
| Alpha-ketoglutarate-dependent dioxygenase FTO | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for pralnacasan and entacapone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |